🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark A. Keibler

Alnylam Pharmaceuticals (United States)

ORCID: 0000-0002-5410-6543

Also affiliated with Massachusetts Institute of Technology

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: Differential substrate use in EGF‐ and oncogenic KRAS‐stimulated human mammary epithelial cells.

6 citations

Wentao Dong, Keegan Korthauer, Aaron M. Hosios, Sun Jin Moon, Lucas B. Sullivan +12 more

8 citations

Mark A. Keibler, Sun Jin Moon, Patricia Cho, Nian Liu, Christian Berrios +7 more

N/A
0DataRank · unranked
2 citations

Mark A. Keibler, Wentao Dong, Jenny Ghelfi, Thekla Cordes, Tamara Kanashova +8 more

6 citations

Mark A. Keibler, Wentao Dong, Jenny Ghelfi, Thekla Cordes, Tamara Kanashova +8 more